Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-06 Sale | 2026-01-08 4:20 pm | Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO | 23,766 | $6.8197 | $162,077 | 323,530 (Direct) | View |
| 2026-01-06 Sale | 2026-01-08 4:19 pm | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 3,573 | $6.8197 | $24,367 | 58,820 (Direct) | View |
| 2026-01-06 Sale | 2026-01-08 4:19 pm | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 10,591 | $6.8197 | $72,227 | 121,220 (Direct) | View |
| 2025-12-04 Purchase | 2025-12-08 4:07 pm | Cartesian Therapeutics Inc. | RNAC | BARABE TIMOTHY C Director | 30,000 | $6.8599 | $205,797 | 54,366 (Direct) | View |
| 2025-04-09 Purchase | 2025-04-11 5:29 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 149,075 | $10.21 | $1,522,517 | 9,630,893 (Indirect Direct) | View |
| 2025-03-18 Purchase | 2025-03-20 7:50 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 89,863 | $15.26 | $1,371,154 | 9,481,818 (Indirect Direct) | View |
| 2025-01-13 Purchase | 2025-01-15 4:08 pm | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 20,967 | $17.47 | $366,354 | 9,391,955 (Indirect Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:05 pm | Cartesian Therapeutics Inc. | RNAC | Kurtoglu Metin Chief Technology Officer | 4,875 | $16.78 | $81,790 | 62,258 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:05 pm | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 1,880 | $16.78 | $31,542 | 35,393 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:05 pm | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 2,550 | $16.78 | $42,783 | 53,490 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:05 pm | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 1,797 | $16.78 | $30,149 | 40,226 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:04 pm | Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO | 17,271 | $16.78 | $289,764 | 204,096 (Direct) | View |
| 2025-01-03 Sale | 2025-01-07 8:04 pm | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 7,989 | $16.78 | $134,036 | 94,811 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-01-02 Option Award | 2026-01-06 4:19 pm | 2027-01-02 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | DeSilva Nishan M Director | 10,400 | $0 | 19,166 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:19 pm | N/A 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO | 558,900 | $0 | 762,996 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:19 pm | 2027-01-02 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | Malik Kemal Director | 10,400 | $0 | 18,933 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:19 pm | N/A 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | Miljkovic Milos Chief Medical Officer | 104,000 | $0 | 139,393 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:18 pm | 2027-01-02 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | ZENNER PATRICK J Director | 10,400 | $0 | 20,774 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:18 pm | N/A 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | Seymour June Ann Chief Accounting Officer | 25,500 | $0 | 25,500 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:18 pm | N/A 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 146,000 | $0 | 240,811 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:18 pm | 2027-01-02 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | BARABE TIMOTHY C Director | 10,400 | $0 | 64,766 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:18 pm | N/A 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 95,000 | $0 | 165,226 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:18 pm | 2027-01-02 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director | 10,400 | $0 | 718,801 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:18 pm | 2027-01-02 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | SPRINGER TIMOTHY A Director 10% Owner | 10,400 | $0 | 9,641,293 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-06 4:18 pm | 2027-01-02 2036-01-01 | Cartesian Therapeutics Inc. | RNAC | Kalayoglu Murat Director 10% Owner | 10,400 | $0 | 5,074,637 (Direct) | View |
| 2025-12-30 Exercise | 2026-01-02 4:03 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 7,500 | $3.3 | 89,595 (Direct) | View |
| 2025-12-30 Exercise | 2026-01-02 4:03 pm | N/A 2031-04-25 | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 7,500 | $0 | 89,595 (Direct) | View |
| 2025-12-16 Option Award | 2025-12-18 5:05 pm | N/A 2035-12-15 | Cartesian Therapeutics Inc. | RNAC | Bot Adrian Ion Director | 23,000 | $0 | 23,000 (Direct) | View |
| 2025-11-28 Exercise | 2025-12-02 4:02 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 7,500 | $3.3 | 89,595 (Direct) | View |
| 2025-11-28 Exercise | 2025-12-02 4:02 pm | N/A 2031-04-25 | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 7,500 | $0 | 89,595 (Direct) | View |
| 2025-11-18 Gift | 2025-11-19 6:35 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Singer Michael Director | 20,000 | $0 | 708,401 (Direct) | View |
| 2025-10-27 Option Award | 2025-10-28 4:05 pm | N/A 2035-10-27 | Cartesian Therapeutics Inc. | RNAC | Seymour June Ann Chief Accounting Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-05-12 Exercise | 2025-05-14 4:15 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 7,500 | $3.3 | 89,595 (Direct) | View |
| 2025-05-12 Exercise | 2025-05-14 4:15 pm | N/A 2031-04-25 | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 7,500 | $0 | 89,595 (Direct) | View |
| 2025-04-15 Exercise | 2025-04-16 4:35 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 7,500 | $3.3 | 89,595 (Direct) | View |
| 2025-04-15 Exercise | 2025-04-16 4:35 pm | N/A 2031-04-25 | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 7,500 | $0 | 89,595 (Direct) | View |
| 2025-01-10 Exercise | 2025-01-13 4:09 pm | N/A 2033-01-15 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 9,000 | $0 | 129,922 (Direct) | View |
| 2025-01-10 Exercise | 2025-01-13 4:09 pm | N/A N/A | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 9,000 | $3.23 | 129,922 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:21 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Brunn Carsten President and CEO | 226,600 | $0 | 589,500 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:21 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Jewell Christopher M Chief Scientific Officer | 63,500 | $0 | 103,440 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:21 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | English Emily Chief Operations Officer | 63,500 | $0 | 89,423 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:20 pm | N/A 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | Davis Blaine Chief Financial Officer | 86,600 | $0 | 271,066 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:20 pm | 2026-01-02 2035-01-01 | Cartesian Therapeutics Inc. | RNAC | ZENNER PATRICK J Director | 10,400 | $0 | 25,774 (Direct) | View |